Ad Koster
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 4
- Emergency Medical Services top 5%
- Central Venous Catheters and Hemodialysis 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 5
-
- Cancer survivorship and care 2
- Hematology top 10%
-
- Diagnosis and Treatment of Venous Diseases 4
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Family Support in Illness 2
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 1
- Co-authors
- John RaemaekersLonneke V. van de Poll‐FranseSimone OerlemansLidwine W. TickFloortje MolsS. VerelstAnton HagenbeekPieter Sonneveld
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Ad Koster
12 papers receiving 481 citations
Peers
Comparison fields: 5 of 51
- Internal Medicine 189
- Emergency Medical Services 108
- Pathology and Forensic Medicine 148
- Oncology 206
- Hematology 81
Countries citing papers authored by Ad Koster
This map shows the geographic impact of Ad Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ad Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ad Koster more than expected).
Fields of papers citing papers by Ad Koster
This network shows the impact of papers produced by Ad Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ad Koster. The network helps show where Ad Koster may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ad Koster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 14 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 37 | |
| 6 | 2020 | 23 | |
| 7 | 2019 | 120 | |
| 8 | 2018 | 21 | |
| 9 | 2017 | 5 | |
| 10 | 2012 | 5 | |
| 11 | 2012 | 100 | |
| 12 | 2008 | 110 | |
| 13 | 2007 | 44 |
About Ad Koster
Ad Koster is a scholar working on Internal Medicine, Emergency Medical Services, Pathology and Forensic Medicine, Oncology and Hematology, having authored 13 papers that have together received 493 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Central Venous Catheters and Hemodialysis (4 papers), Diagnosis and Treatment of Venous Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Cancer survivorship and care (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Family Support in Illness (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper). The work is most often cited by research in Internal Medicine (189 citations), Emergency Medical Services (108 citations), Pathology and Forensic Medicine (148 citations), Oncology (206 citations) and Hematology (81 citations). Ad Koster has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include John Raemaekers, Lonneke V. van de Poll‐Franse, Simone Oerlemans, Lidwine W. Tick, Floortje Mols, S. Verelst, Anton Hagenbeek, Pieter Sonneveld, S. H. Heisterkamp and Daphne de Jong. Their work appears in journals such as Haematologica, Cancer, Journal of Clinical Oncology, European Journal Of Haematology and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.